- Business Wire•yesterdaySynergy Pharmaceuticals Announces New Plecanatide Data Presentations at Upcoming Scientific Meeting and Provides Update on IBS-C Program
Synergy Pharmaceuticals Inc. today announced that the company will present new data on plecanatide, an investigational compound for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation , at the American College of Gastroenterology annual scientific meeting at The Venetian in Las Vegas, October 14-19, 2016.
- Business Wire•6 days ago
Synergy Pharmaceuticals Inc. today announced the company will present at the OctoberINVESTfest Conference on Wednesday, September 28, 2016 at 11:30 a.m. Eastern Time at the New York Academy of Sciences in New York.
- TheStreet.com•15 days ago
Synergy Pharma (SGYP) stock is rising on Wednesday as Citi said the company could be a potential target for Takeda Pharmaceutical (TKPYY).
Synergy Pharmaceuticals, Inc. (SGYP)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||5.43 x 2400|
|Ask||5.44 x 1500|
|Day's Range||5.35 - 5.59|
|52wk Range||2.50 - 7.15|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-4.41|
|Avg Vol (3m)||2,988,032|
|Dividend & Yield||N/A (N/A)|